SLC39A4 and familial pancreatic carcinoma: Recent studies have shown that ZIP4 upregulation in pancreatic cancer promotes the IL-6/STAT3 signalling pathway and activates the production of neuropilin-1 and vascular endothelial growth factor (VEGF), thereby enhancing tumour growth and angiogenesis [78].